Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
NCT: NCT04015700 · ACTIVE_NOT_RECRUITING
Publicidade
ID NCTNCT04015700
EstadoACTIVE_NOT_RECRUITING
Data de início2020-07-14
Conclusão2027-09-03
Resumo breve
This is a single institution, open-label, single arm, study assessing the safety, feasibility, and immunogenicity of a personalized neoantigen-based vaccine in subjects with newly diagnosed, unmethylated glioblastoma.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.